About
Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care. Ipsen develops and commercializes innovative medicines in three key therapeutic areas: oncology, neuroscience, and rare disease. Its dedication to oncology is exemplified by its expanding portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 34 investors are based in Boulogne-billancourt, Ile-de-France, France.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Boulogne-billancourt, France
Contact Information
Find more investors like Ipsen
Search Investors